Adecuación y efecto del tratamiento antiepiléptico preventivo tras una primera crisis epiléptica a los 30 días del alta

Manuel Liñán López(Hospital Universitario Virgen de las Nieves), Susana Martínez-Álvarez(Hospital Universitario La Paz), Raúl Alonso Avilés(Hospital Clínico Universitario de Valladolid), Manuel Fuentes(Hospital Clínico San Carlos), Cesáreo Fernández Alonso(Hospital Clínico San Carlos), Félix González-Martínez

Unknown

January 1, 2019

Cited by 0

Related Papers

The <scp>CD</scp>4:<scp>CD</scp>8 ratio is associated with markers of age‐associated disease in virally suppressed <scp>HIV</scp>‐infected patients with immunological recovery

|HIV Medicine|2013|154

Inhaled Methoxyflurane Provides Greater Analgesia and Faster Onset of Action Versus Standard Analgesia in Patients With Trauma Pain: InMEDIATE: A Randomized Controlled Trial in Emergency Departments

|Annals of Emergency Medicine|2019|74

Clinical presentation and outcome across age categories among patients with COVID-19 admitted to a Spanish Emergency Department

|European Geriatric Medicine|2020|66

Preventive Efficacy of Tenofovir/Emtricitabine Against Severe Acute Respiratory Syndrome Coronavirus 2 Among Pre-Exposure Prophylaxis Users

|Open Forum Infectious Diseases|2020|56

Diagnosis of subclinical atherosclerosis in HIV-infected patients: higher accuracy of the D:A:D risk equation over Framingham and SCORE algorithms

|European Journal of Preventive Cardiology|2012|38